8-K

Company

BridgeBio Pharma, Inc.

Filed

July 3, 2019

Period of Report

June 26, 2019

Accession Number

0001193125-19-189260

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →